{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:49:50Z","timestamp":1786121390727,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LTGY23H180007"],"award-info":[{"award-number":["LTGY23H180007"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02066"],"award-info":[{"award-number":["2025C02066"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.acra.2026.07.041","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:24:00Z","timestamp":1785983040000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiomics Model Predicts Efficacy of First-Line CDK4\/6 Inhibitor Combined with Endocrine Therapy in HR+\/HER2\u2212 Advanced Breast Cancer"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2503-691X","authenticated-orcid":false,"given":"Ying","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.acra.2026.07.041_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0459","article-title":"Breast cancer: presentation, investigation and management","volume":"83","author":"Katsura","year":"2022","journal-title":"Br J Hosp Med ((Lond))"},{"issue":"3","key":"10.1016\/j.acra.2026.07.041_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13304-017-0424-1","article-title":"Breast cancer in young women: an overview","volume":"69","author":"Anastasiadi","year":"2017","journal-title":"Updates Surg"},{"issue":"9","key":"10.1016\/j.acra.2026.07.041_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5603\/GP.2016.0062","article-title":"Breast cancer in young women","volume":"87","author":"Radecka","year":"2016","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.acra.2026.07.041_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103924","article-title":"Metaplastic breast cancer: A review","volume":"182","author":"Thomas","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.acra.2026.07.041_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"10.1016\/j.acra.2026.07.041_bib6","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.acra.2026.07.041_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer Treatment: A Review","volume":"321","author":"Waks","year":"2019","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.acra.2026.07.041_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2017-0535","article-title":"Luminal A Breast Cancer and Molecular Assays: A Review","volume":"23","author":"Gao","year":"2018","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.acra.2026.07.041_bib9","first-page":"934","article-title":"Clinical benefit and safety profile of cross-line therapy with CDK4\/6 inhibitors: a retrospective study of HR+\/HER2- advanced breast cancer","volume":"21","author":"Zhao","year":"2024","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.acra.2026.07.041_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: Biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.acra.2026.07.041_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41571-024-00935-6","article-title":"Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer","volume":"21","author":"Lloyd","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.acra.2026.07.041_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41571-023-00840-4","article-title":"The CDK4\/6 inhibitor revolution - a game-changing era for breast cancer treatment","volume":"21","author":"Morrison","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.acra.2026.07.041_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102980","article-title":"Overcoming Resistance to CDK4\/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies","volume":"139","author":"Giugliano","year":"2025","journal-title":"Cancer Treat Rev"},{"issue":"9","key":"10.1016\/j.acra.2026.07.041_bib14","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1158\/1078-0432.CCR-24-2307","article-title":"ESR1 Y537S and D538G Mutations Drive Resistance to CDK4\/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer","volume":"31","author":"Lin","year":"2025","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.acra.2026.07.041_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.semcancer.2020.12.005","article-title":"Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy","volume":"84","author":"Wu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.acra.2026.07.041_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.breast.2019.10.018","article-title":"Overview of radiomics in breast cancer diagnosis and prognostication","volume":"49","author":"Tagliafico","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.acra.2026.07.041_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","article-title":"Radiomics in breast cancer classification and prediction","volume":"72","author":"Conti","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"10.1016\/j.acra.2026.07.041_bib18","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.acra.2022.09.012","article-title":"Radiomics and Breast Cancer Management","volume":"29","author":"Dean","year":"2022","journal-title":"Acad Radiol"},{"issue":"4","key":"10.1016\/j.acra.2026.07.041_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11912-023-01372-x","article-title":"Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis","volume":"25","author":"Wekking","year":"2023","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"10.1016\/j.acra.2026.07.041_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.acra.2019.09.012","article-title":"Breast Cancer Radiogenomics: Current Status and Future Directions","volume":"27","author":"Grimm","year":"2020","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1016\/j.acra.2026.07.041_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"35","key":"10.1016\/j.acra.2026.07.041_bib22","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1200\/JCO.21.01392","article-title":"Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update","volume":"39","author":"Burstein","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.acra.2026.07.041_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076834","article-title":"A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.acra.2026.07.041_bib24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/jmri.27948","article-title":"Editorial for \"Evaluating Tumor-Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI-based Radiomics\"","volume":"55","author":"Moran","year":"2022","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"10.1016\/j.acra.2026.07.041_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13058-018-1050-7","article-title":"Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial","volume":"20","author":"Hortobagyi","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.acra.2026.07.041_bib26","article-title":"Real-World Outcomes of CDK4\/6 Inhibitors Treatment in Metastatic Breast Cancer in Romania","volume":"13","author":"Miron","year":"2023","journal-title":"Diagnostics ((Basel))"},{"issue":"8","key":"10.1016\/j.acra.2026.07.041_bib27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/oncolo\/oyac089","article-title":"Real-World Experience with CDK4\/6 Inhibitors for Metastatic HR+\/HER2- Breast Cancer at a Single Cancer Center","volume":"27","author":"Knudsen","year":"2022","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.acra.2026.07.041_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/path.6358","article-title":"A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4\/6 inhibitors","volume":"264","author":"Segatto","year":"2024","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.acra.2026.07.041_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41523-023-00574-7","article-title":"Radiomic predicts early response to CDK4\/6 inhibitors in hormone receptor positive metastatic breast cancer","volume":"9","author":"Khorrami","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.acra.2026.07.041_bib30","article-title":"Delta-CT radiomics based model for predicting postoperative anastomotic leakage following radical resection of esophageal squamous cell carcinoma","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.acra.2026.07.041_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: Images Are More than Pictures, They Are Data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226005489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226005489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:31:00Z","timestamp":1786077060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226005489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S1076633226005489"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.07.041","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiomics Model Predicts Efficacy of First-Line CDK4\/6 Inhibitor Combined with Endocrine Therapy in HR+\/HER2\u2212 Advanced Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}